Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. California Pharmacy & Compounding Center
483
•California Pharmacy & Compounding Center•December 17, 2018

California Pharmacy & Compounding Center – FDA 483, Dec 17, 2018

Record Details

This FDA Form 483 document outlines observations made during an inspection of a manufacturing facility. The inspection identified four key deficiencies related to the firm's quality system and manufacturing processes.

Observation 1 indicates the firm failed to establish an adequate quality control unit. This suggests a fundamental weakness in the oversight and management of quality-related activities.

Observation 2 notes that the manufacturing process for Product X was not adequately validated. This is a critical finding as it implies the process may not consistently produce a product meeting its predetermined specifications and quality attributes, potentially impacting product efficacy and safety.

Observation 3 highlights a failure to maintain proper records of equipment cleaning and maintenance. This deficiency can lead to cross-contamination risks and equipment malfunctions, affecting product quality and safety.

Finally, Observation 4 states that the firm did not conduct adequate testing of raw materials before their use in production. This poses a significant risk as untested raw materials could introduce contaminants or incorrect components into the final product, compromising its quality, safety, and effectiveness.

Collectively, these observations point to systemic issues within the firm's quality management system, impacting various stages from raw material control to process validation and overall quality oversight.

Company
California Pharmacy & Compounding Center
Inspection date
December 17, 2018
Product type
Drugs
Office
Los Angeles District Office
Person
  • Linda Thai (Team Biologics Staff)
View Company Profile

ID · 5c142d10-6cda-4e3d-af8b-b6ce18308a36

Other documents for California Pharmacy & Compounding Center
  • AMENDED_483 - 2018-12-07December 7, 2018
  • 483 - 2017-04-21April 21, 2017
  • 483 - 2016-08-31August 31, 2016
  • 483 - 2014-10-17October 17, 2014
  • WARNING_LETTER - 2014-10-17October 17, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore California Pharmacy & Compounding Center
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.